{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:49:21Z","timestamp":1790261361743,"version":"4.1.0"},"reference-count":38,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":3696,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The receptor activator of nuclear factor-\u03baB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL\/RANK\/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MAC) seen in people with CN are unclear. This study aimed to investigate the role of RANKL\/OPG in MAC in patients with CN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Enzyme-linked immunosorbent assay and Bio-plex multiarray technology were used to quantify a range of cytokines, including RANKL and OPG in sera from 10 patients with diabetes, 12 patients with CN, and 5 healthy volunteers. Human tibial artery segments were immunohistochemically stained with Alizarin red and human RANKL antibody. Human vascular smooth muscle cells (VSMCs) were also explanted from arterial segments for in vitro studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We demonstrate colocalization and upregulation of RANKL expression in areas displaying MAC. Systemic levels of RANKL, OPG, and inflammatory cytokines (interleukin-8, granulocyte colony\u2013stimulating factor) were elevated in those with CN compared with diabetic patients and healthy control subjects. Human VSMCs cultured in CN serum showed accelerated osteoblastic differentiation (alkaline phosphatase activity) and mineralization (alizarin red staining) compared with cells treated with diabetic or control serum (P &amp;lt; 0.05). Coincubation with OPG, the decoy receptor for RANKL, attenuated osteogenic differentiation of VSMCs and was independent of a high calcium-phosphate milieu. The accelerated mineralization induced by RANKL and CN serum correlated with nuclear translocation of nuclear factor-\u03baB, a process abrogated by OPG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our data provide direct evidence that RANKL\/RANK\/OPG signaling is modulated in patients with CN and plays a role in vascular calcification. This study highlights this pathway as a potential target for intervention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db10-1220","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T08:55:51Z","timestamp":1307696151000},"page":"2187-2196","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":111,"title":["The RANKL\/RANK\/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy"],"prefix":"10.2337","volume":"60","author":[{"given":"Agbor","family":"Ndip","sequence":"first","affiliation":[{"name":"Department of Medicine and Diabetes, Manchester Royal Infirmary, Manchester, U.K."},{"name":"Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Williams","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Jude","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K."},{"name":"Diabetes Centre, Tameside General Hospital, Ashton-Under-Lyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Serracino-Inglott","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Manchester Royal Infirmary, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Manchester Royal Infirmary, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.","family":"Smyth","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Manchester Royal Infirmary, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.M.","family":"Boulton","sequence":"additional","affiliation":[{"name":"Department of Medicine and Diabetes, Manchester Royal Infirmary, Manchester, U.K."},{"name":"Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Yvonne","family":"Alexander","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"key":"2022031223372532700_B1","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/diacare.17.11.1252","article-title":"Medial artery calcification predicts cardiovascular mortality in patients with NIDDM","volume":"17","author":"Niskanen","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031223372532700_B2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.ATV.16.8.978","article-title":"Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus","volume":"16","author":"Lehto","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031223372532700_B3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diacare.11.1.8","article-title":"Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians","volume":"11","author":"Nelson","year":"1988","journal-title":"Diabetes Care"},{"key":"2022031223372532700_B4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"2022031223372532700_B5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00404070","article-title":"Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"2022031223372532700_B6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11892-003-0049-2","article-title":"Arterial calcification in diabetes","volume":"3","author":"Chen","year":"2003","journal-title":"Curr Diab Rep"},{"key":"2022031223372532700_B7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.metabol.2006.08.012","article-title":"Lower-extremity arterial calcification as a correlate of coronary artery calcification","volume":"55","author":"Costacou","year":"2006","journal-title":"Metabolism"},{"key":"2022031223372532700_B8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-003-0011-y","article-title":"Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease","volume":"74","author":"Sattler","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"2022031223372532700_B9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-004-1477-5","article-title":"Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?","volume":"47","author":"Jeffcoate","year":"2004","journal-title":"Diabetologia"},{"key":"2022031223372532700_B10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","article-title":"Increased osteoclastic activity in acute Charcot\u2019s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand","volume":"51","author":"Mabilleau","year":"2008","journal-title":"Diabetologia"},{"key":"2022031223372532700_B11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031223372532700_B12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1359-6101(03)00027-3","article-title":"Biology of the TRANCE axis","volume":"14","author":"Walsh","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022031223372532700_B13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2022031223372532700_B14","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1096\/fj.02-1188fje","article-title":"The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes","volume":"17","author":"Breuil","year":"2003","journal-title":"FASEB J"},{"key":"2022031223372532700_B15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ Res"},{"key":"2022031223372532700_B16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0958-2592(95)90013-6","article-title":"The Charcot foot","volume":"5","author":"Shaw","year":"1995","journal-title":"The Foot"},{"key":"2022031223372532700_B17"},{"key":"2022031223372532700_B18","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"2022031223372532700_B19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1530\/EJE-06-0753","article-title":"The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study","volume":"156","author":"Stern","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2022031223372532700_B20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/path.2114","article-title":"Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development","volume":"211","author":"Wilkinson","year":"2007","journal-title":"J Pathol"},{"key":"2022031223372532700_B21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.RES.0000223056.68892.8b","article-title":"Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification","volume":"98","author":"Kirton","year":"2006","journal-title":"Circ Res"},{"key":"2022031223372532700_B22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/dc06-2168","article-title":"Is there a systemic inflammatory response in the acute Charcot foot?","volume":"30","author":"Petrova","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031223372532700_B23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","article-title":"Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot","volume":"33","author":"Uccioli","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031223372532700_B24","first-page":"144","article-title":"Osteoprotegerin and inflammation","volume":"13","author":"Saidenberg Kermanac\u2019h","year":"2002","journal-title":"Eur Cytokine Netw"},{"issue":"Suppl 2","key":"2022031223372532700_B25","doi-asserted-by":"crossref","first-page":"ii82","DOI":"10.1136\/ard.61.suppl_2.ii82","article-title":"Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis","volume":"61","author":"Lam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2022031223372532700_B26","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"2022031223372532700_B27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/ard.2009.121764","article-title":"Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis","volume":"69","author":"van Tuyl","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022031223372532700_B28","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.21896","article-title":"The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction","volume":"54","author":"Geusens","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022031223372532700_B29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bone.2006.08.003","article-title":"Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget\u2019s disease of bone","volume":"40","author":"Martini","year":"2007","journal-title":"Bone"},{"key":"2022031223372532700_B30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.10834","article-title":"Serum osteoprotegerin and its ligand in Paget\u2019s disease of bone: relationship to disease activity and effect of treatment with bisphosphonates","volume":"48","author":"Alvarez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2022031223372532700_B31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1359\/jbmr.090802","article-title":"Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women","volume":"25","author":"Pino","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2022031223372532700_B32","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00198-005-1844-1","article-title":"The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women","volume":"16","author":"Mezquita-Raya","year":"2005","journal-title":"Osteoporos Int"},{"key":"2022031223372532700_B33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000196280","article-title":"Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women","volume":"55","author":"Chiba","year":"2009","journal-title":"Gerontology"},{"key":"2022031223372532700_B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"2022031223372532700_B35","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/jc.2003-031432","article-title":"Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in M\u00f6nckeberg\u2019s sclerosis and atherosclerosis","volume":"89","author":"Schoppet","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031223372532700_B36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20030116","article-title":"The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis","volume":"198","author":"Novack","year":"2003","journal-title":"J Exp Med"},{"key":"2022031223372532700_B37","doi-asserted-by":"crossref","first-page":"54841","DOI":"10.1074\/jbc.M406392200","article-title":"Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha","volume":"279","author":"Chaisson","year":"2004","journal-title":"J Biol Chem"},{"key":"2022031223372532700_B38","doi-asserted-by":"crossref","first-page":"29925","DOI":"10.1074\/jbc.M110.117366","article-title":"PKA-induced receptor activator of NF-\u03baB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification","volume":"285","author":"Tseng","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/60\/8\/2187\/508856\/2187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/60\/8\/2187\/508856\/2187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:24:41Z","timestamp":1667406281000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/60\/8\/2187\/33608\/The-RANKL-RANK-OPG-Signaling-Pathway-Mediates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,18]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,7,18]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db10-1220","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,18]]}}}